MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 219 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2022. The put-call ratio across all filers is 4.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $807 | -99.9% | 24,300 | -8.6% | 0.00% | 0.0% |
| Q3 2022 | $838,000 | +67.3% | 26,600 | +61.2% | 0.00% | +100.0% |
| Q2 2022 | $501,000 | +24.6% | 16,500 | +6.5% | 0.00% | +100.0% |
| Q1 2022 | $402,000 | +1.5% | 15,500 | +2.6% | 0.00% | 0.0% |
| Q1 2021 | $396,000 | -43.8% | 15,100 | -59.9% | 0.00% | -66.7% |
| Q4 2020 | $704,000 | +10.0% | 37,700 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $640,000 | -21.0% | 37,700 | +8.3% | 0.00% | -25.0% |
| Q2 2020 | $810,000 | – | 34,800 | – | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2015 | $22,000 | +22.2% | 1,100 | 0.0% | 0.00% | – |
| Q3 2015 | $18,000 | -97.3% | 1,100 | -96.3% | 0.00% | -100.0% |
| Q1 2014 | $657,000 | -38.7% | 30,135 | -25.4% | 0.00% | -40.0% |
| Q4 2013 | $1,072,000 | -6.9% | 40,400 | -17.0% | 0.01% | 0.0% |
| Q3 2013 | $1,152,000 | +8.7% | 48,700 | -1.2% | 0.01% | 0.0% |
| Q2 2013 | $1,060,000 | – | 49,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |